High symptom scores for tiredness, poor well-being, pain, and drowsiness may prompt AYA patients with cancer to seek medical assistance in dying.

Aims To evaluate whether predominantly peripheral lesions (PPLs) and other imaging biomarkers on ultra-widefield (UWF) ...

Background:Maternal chronic conditions are implicated as risk factors for congenital anomalies, but few studies have assessed ...

Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...

Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...

BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and Lymphoma Early-phase clinical trials (EPCTs) have been ...

South Korean study found no increased risk for 12 disorders among exposed offspring ...

Do psoriasis systemic treatments raise serious infection risk? Real-world BADBIR data compares therapies and outcomes. Find ...

Achieved the primary objective with favorable safety and tolerability, no discontinuations and no serious adverse events ---- ...

Prognostic genomic signatures in patients with RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC) from the phase III study of first-line FOLFIRI/cetuximab versus FOLFIRI/cetuximab ...